JUL 04, 2018 2:45 AM PDT

Identifying New Drug Targets in Therapy-Resistant Cancers

WRITTEN BY: Nouran Amin

Recent research published in the Nature Partner journal Systems Biology and Applications examines how genome-wide data used in collaboration with systems biology analyses can potentially identify master regulators and new drug targets of therapy-resistant cancers.

The findings explain how cancer takes hold and controls certain effector networks, a crucial area for the future of cancer therapy.

 

Cancer researchers are aware of the significance of epigenomic control in development and disease processes. To determine which cellular programs are silent and which are active, epigenomic signals beyond the genetic code of the DNA.

“Epigenomics does not directly affect the DNA itself,” Professor Fabian V. Filipp said. “A hidden layer of regulation controls the activity of genes. In cancer, if we disregard or insufficiently understand epigenomic networks, tumor cells have the ability to rapidly adapt to drug treatment and resistance may arise.”

 

To accomplish target-specificity, epigenetic master regulators in cancer allow target-specificity of their phenotypic program in cooperation with members of the transcriptional machinery. Therefore, the cancer systems biology research team at UC Merced developed a universal workflow for the elucidation of regulatory cooperation networks.

 

“By integrating different genomic features of complementary epigenomic and transcriptomic data, a highly specific and hyperconnected network can be identified,” explains Flipp.

 

Epigenomic target regions can define accessible bile chromatin and determine the target genes.

 

"The research portfolio of Professor Filipp builds an important bridge between clinical and computational sciences," Vice Chancellor for Research Samuel Traina said. "Professor Filipp runs an interdisciplinary research program that serves and positively impacts the educational needs of California's Central Valley".

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAY 04, 2021
Cell & Molecular Biology
A Potential Weakness in SARS-CoV-2 is Caught on Video
MAY 04, 2021
A Potential Weakness in SARS-CoV-2 is Caught on Video
You can see the spike protein of the virus in action in this video.
MAY 13, 2021
Health & Medicine
New Peptide Allows Cannabis to Fight Pain With Fewer Side Effects
MAY 13, 2021
New Peptide Allows Cannabis to Fight Pain With Fewer Side Effects
THC-rich cannabis is well known to bring relief for some chronic pain sufferers. But the downside, off putting for many ...
MAY 18, 2021
Immunology
A Silver Bullet Against COVID Variants?
MAY 18, 2021
A Silver Bullet Against COVID Variants?
Canadian researchers have discovered an antiviral drug that blocks the SARS-CoV-2 virus from infecting lung cells. Promi ...
JUN 14, 2021
Health & Medicine
Another Benefit of Aspirin: Decreased Colorectal Cancer Risk When Started Early
JUN 14, 2021
Another Benefit of Aspirin: Decreased Colorectal Cancer Risk When Started Early
Valued for stroke and heart attack prevention, aspirin is also recommended for colorectal cancer prevention. A Harv ...
JUL 12, 2021
Drug Discovery & Development
Testosterone Supplements Reduce Heart Attack and Stroke Risk
JUL 12, 2021
Testosterone Supplements Reduce Heart Attack and Stroke Risk
Taking testosterone supplements significantly reduces risk of heart attack and stroke among men with low levels of the h ...
JUL 15, 2021
Drug Discovery & Development
The genomics of high blood pressure - a road to the future of treatment
JUL 15, 2021
The genomics of high blood pressure - a road to the future of treatment
The human heart begins to beat in utero in the early weeks of development and continues throughout life. In an average l ...
Loading Comments...